Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | Director · President and CEO | February 12, 2026 | February 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date February 12, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,169 |
Ending reported balance
After 2026-02-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-15 · Exercise / conversion · Acquired 16,665 · Balance 83,602 F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Row 2 · 2026-02-15 · Tax withholding · Disposed 6,433 · Balance 77,169 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-15 · Exercise / conversion · Disposed 16,665 · Balance 0 F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 100,000 |
Reported balance
After 2026-02-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-12 · Grant · Acquired 100,000 · Balance 100,000 F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.71 · Expires 2036-02-12 | Direct | 595,000 |
Reported balance
After 2026-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-12 · Grant · Acquired 595,000 · Balance 595,000 F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2019 Filed Feb 25, 2019 21:03 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 85,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000034 · wf-form4_155112859605813.xml · derivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| January 28, 2019 Filed Jan 28, 2019 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-19-000010 · wf-form4_154870993915153.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,497 Underlying: Common Stock · 6,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of expiring options. F2 · balance_after: 4,000 stock options were inadvertently omitted from the total amount of derivative securities beneficially owned and reported on the Form 4 filed by the reporting person on October 23, 2018. The amount in Table II, Column 9 reflects the corrected amount of derivative securities beneficially owned by the reporting person following the transaction reported herein. Read SEC document |
| January 28, 2019 Filed Jan 28, 2019 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 6,000 | $0.94 | $5,640.00 |
DisclosureSEC source: 0001125345-19-000010 · wf-form4_154870993915153.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 21:39 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000109 · wf-form4_154473716711792.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,497 Underlying: Common Stock · 5,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 21:39 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,000 | $0.94 | $4,700.00 |
DisclosureSEC source: 0001125345-18-000109 · wf-form4_154473716711792.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes 792 shares acquired under the MacroGenics, Inc. Employee Stock Purchase Plan (ESPP) on May 31, 2018, and 417 shares acquired under the ESPP on November 30, 2018. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 21:48 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000103 · wf-form4_154223210952380.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,497 Underlying: Common Stock · 4,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 21:48 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 4,000 | $0.94 | $3,760.00 |
DisclosureSEC source: 0001125345-18-000103 · wf-form4_154223210952380.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 23, 2018 16:32 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000088 · wf-form4_154031231718754.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,497 Underlying: Common Stock · 3,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 23, 2018 16:32 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000088 · wf-form4_154031231718754.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000051 · wf-form4_152106190721065.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,497 Underlying: Common Stock · 1,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 1,000 | $31.08 | $31,080.00 |
DisclosureSEC source: 0001125345-18-000051 · wf-form4_152106190721065.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.94 to $31.23. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001125345-18-000051 · wf-form4_152106190721065.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000044 · wf-form4_152037504013275.xml · derivative · entry 4 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,497 Underlying: Common Stock · 4,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 70,000 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000044 · wf-form4_152037504013275.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-03-02 F3 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 4,000 | $30.00 | $120,000.00 |
DisclosureSEC source: 0001125345-18-000044 · wf-form4_152037504013275.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.05.The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 4,000 | $0.94 | $3,760.00 |
DisclosureSEC source: 0001125345-18-000044 · wf-form4_152037504013275.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000031 · wf-form4_151994305645663.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,497 Underlying: Common Stock · 1,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 1,000 | $25.01 | $25,005.00 |
DisclosureSEC source: 0001125345-18-000031 · wf-form4_151994305645663.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.01.The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001125345-18-000031 · wf-form4_151994305645663.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 22:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000012 · wf-form4_151691894605441.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,497 Underlying: Common Stock · 3,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 22:22 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,000 | $22.50 | $67,500.00 |
DisclosureSEC source: 0001125345-18-000012 · wf-form4_151691894605441.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.50 to $20.51. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 22:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000012 · wf-form4_151691894605441.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:01 UTC Amendment | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000014 · wf-form4a_151700049576402.xml · derivative · entry 3 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,497 Underlying: Common Stock · 3,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:01 UTC Amendment | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,000 | $22.50 | $67,500.00 |
DisclosureSEC source: 0001125345-18-000014 · wf-form4a_151700049576402.xml · nonDerivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17. F2 · price: The Form 4, as originally filed on 1/25/18, incorrectly reported the sale price. The Form 4, as amended by this Form 4/A, correctly reports such information. F3 · price: The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:01 UTC Amendment | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000014 · wf-form4a_151700049576402.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000006 · wf-form4_151631394773382.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,497 Underlying: Common Stock · 2,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 2,000 | $0.94 | $1,880.00 |
DisclosureSEC source: 0001125345-18-000006 · wf-form4_151631394773382.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount includes 1,100 shares purchased through the Company's ESPP; 800 on 5/31/17 and 300 on 11/30/17. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:52 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-17-000095 · wf-form4_150481753175250.xml · derivative · entry 2 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,497 Underlying: Common Stock · 2,000 shares Expires 2019-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total reported in Column 9 has been adjusted to correct a prior calculation error in the Form 4 filed by the reporting person on February 8, 2016, which understated the total number of shares. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:52 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 2,000 | $0.94 | $1,880.00 |
DisclosureSEC source: 0001125345-17-000095 · wf-form4_150481753175250.xml · nonDerivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 22:45 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantCommon Stock · Derivative | 55,000 | $20.53 Strike: $20.53 | $1,129,150.00 |
DisclosureSEC source: 0001125345-17-000032 · wf-form4_148728510924105.xml · derivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2027-02-15 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 22:11 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001552781-16-001951 · e00507_risser-form4.xml · derivative · entry 1 Risser Eric Blasius · CIK 0001587774 · Sr VP & Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: 12.5% of the option becomes exercisable on March 14, 2017 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.